Simple Summary Immunotherapy helps a person's immune system to target tumor cells.
Recent advances in cancer immunotherapy, including immune checkpoint inhibition …

Simple Summary Immune checkpoint inhibitors (ICIs) are an important strategy in cancer
therapy. However, with the widespread clinical use of ICIs, people gradually found that ICIs …

Immune checkpoint inhibitors (ICIs) targeting programmed cell death-1 (PD-1 or CD279)
have noticeably improved the treatment landscape of advanced cancer patients. Nivolumab …

T cell-based immunotherapy, which tackles T cell dysfunction and exhaustion, offers broad
promising for treating cancer. Various T cell-based immunotherapies, such as immune …

The human gut microbiota are critical for preserving the health status because they are
required for digestion and nutrient acquisition, the development of the immune system, and …

The incidence of liver cancer is continuously rising where hepatocellular carcinoma (HCC)
remains the most common form of liver cancer accounting for approximately 80–90% of the …

The tumor microenvironment (TME) is a significant contributor to cancer progression
containing complex connections between cellular and chemical components and provides a …

Various immunotherapeutic agents that can elicit antitumor immune responses have
recently been developed with the potential for improved efficacy in treating cancer. However …

With the goal of harnessing the host's immune system to provide long-lasting remission and
cures for various cancers, the advent of immunotherapy revolutionized the cancer therapy …

Currently, tumor treatment research still focuses on the cancer cells themselves, but the fact
that the immune system plays an important role in inhibiting tumor development cannot be …